Skip to main content

Fiscal Wizard · Single-issue tearsheet

AUPH / Jun 21, 2026 Run #7411

AUPH

Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.

Composite verdict

A 92.3 / 100
Bullish setup · Trend Following 12 drivers · 4 gates blocking
  • Accumulation/Distribution Line
  • 52-Week Proximity
  • Chaikin Money Flow
Consider long call target Δ ~0.70 · ~35 DTE Bullish setup, Grade A → ITM call target

Industry rank 5th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: range
Bull 100%Evidence: High · 22 signals0% Bear
Momentum Bullish 99Mean-reversion Neutral 50

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -66%
Asset value $4.52Earnings power value $7.20Price $16.46

Priced above its no-growth earnings power value ($7.20/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Strong

84.6 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Margin of Safety 0
Revenue Growth (YoY) 100
OCF to Net Income 0
Earnings Yield 100
Cash Conversion 0

Technicals Bullish

100.0 / 100

Bullish setup leads (Accumulation/Distribution Line, 52-Week Proximity, Chaikin Money Flow); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Accumulation/Distribution Line 96
Chaikin Money Flow 89
Vortex Signal 88

Risk Gates

4 blocking 4 caution

4 guards active, 17 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for AUPH.